Sampre Nutritions Allots 76.21 Lakh Equity Shares Following FCCB Conversion Worth $1.3 Million

1 min read     Updated on 22 Dec 2025, 09:06 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Sampre Nutritions Limited has completed the conversion of 13 Foreign Currency Convertible Bonds (FCCBs) worth $1.3 million into equity shares. The conversion resulted in the allotment of 76,21,493 new equity shares at a conversion price of ₹14.96 per share. This action increases the company's paid-up share capital to ₹47,50,44,565, with a total of 9,50,08,913 outstanding shares. The conversion was approved by the board on December 22, 2025, following a request from an FCCB holder.

27963388

*this image is generated using AI for illustrative purposes only.

Sampre Nutritions Limited has successfully completed the allotment of equity shares following the conversion of Foreign Currency Convertible Bonds (FCCBs), marking a significant development in the company's capital structure. The board of directors approved this conversion at their meeting held on December 22, 2025.

FCCB Conversion Details

The company converted 13 FCCBs with a total principal value of $1.30 million (United States Dollar One million three hundred thousand). This conversion resulted from a notice received from an FCCB holder requesting the conversion of their bonds into equity shares.

Parameter Details
FCCBs Converted 13 bonds
Principal Value $1,300,000
Conversion Price ₹14.96 per share
Face Value ₹5.00 per share
Shares Allotted 76,21,493 equity shares

Share Capital Impact

Following this allotment, the company's financial structure has been strengthened with an expanded equity base. The conversion has resulted in a substantial increase in the total number of outstanding shares.

Metric Post-Conversion
Paid-up Share Capital ₹47,50,44,565
Total Equity Shares 9,50,08,913 shares
Face Value per Share ₹5.00

Background and Timeline

Sampre Nutritions had originally allotted 100 FCCBs on June 28, 2024, as part of its fundraising initiative. The recent conversion represents a portion of these bonds being exercised by holders who opted to convert their debt instruments into equity participation.

The board meeting that approved this conversion commenced at 4:00 PM IST and concluded at 6:00 PM IST on December 22, 2025. The decision was made in accordance with the terms outlined in the Offering Memorandum that governed the FCCB issuance.

Regulatory Compliance

The allotment was conducted under Regulation 30 of the Securities and Exchange Board of India (SEBI) regulations, ensuring full compliance with disclosure requirements. The company has duly informed BSE Limited about this development, maintaining transparency with stakeholders and regulatory authorities.

Historical Stock Returns for Sampre Nutritions

1 Day5 Days1 Month6 Months1 Year5 Years
+0.04%-8.18%-14.70%+223.72%+40.12%+350.09%
Sampre Nutritions
View in Depthredirect
like15
dislike
Explore Other Articles
25.25
+0.01
(+0.04%)